Browse studies
Find your next paid study
3 recruiting studies matching your filters
Phase 2
A Phase 2 Randomized, Placebo-Controlled Clinical Trial to Assess the Safety and Efficacy of Donanemab in Participants With Early Cognitive Decline, at Least One Core Clinical Feature of Dementia With Lewy Bodies, and Confirmation of Alpha-Synuclein and Amyloid Co-pathology
The main purpose of this study is to evaluate whether treatment with donanemab slows the progression of cognitive (how we think, learn, remember, pay attention…
Cognitive DysfunctionLewy Body DiseaseSynucleinopathies+1 more
Estimated
~$10 – $7,500
Eli Lilly and CompanyNCT07589595
Natural History Study of Synucleinopathies
Synucleinopathies are a group of rare diseases associated with worsening neurological deficits and the abnormal accumulation of the protein α-synuclein in the …
Patients With SynucleinopathiesNeurogenic Orthostatic HypotensionPure Autonomic Failure+5 more
Estimated
~$10 – $1,125
NYU Langone HealthNCT01799915
ObservationalRemote eligible
Slow-SPEED: Slowing Parkinson's Early Through Exercise Dosage
The goal of this clinical trial is two-fold. First to investigate the feasibility of whether a remotely administered smartphone app can increase the volume and…
Parkinson DiseaseProdromal StageNeurodegenerative Diseases+8 more
Estimated
~$10 – $6,250
Radboud University Medical CenterNCT06993142